BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8187957)

  • 1. Inhibitory effects of cyclosporin A on rat insulinoma cell proliferation, polyamine content and insulin secretion.
    Sjöholm A
    Mol Cell Endocrinol; 1994 Feb; 99(1):21-4. PubMed ID: 8187957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicotinamide on clonal rat insulinoma cell proliferation, polyamine content and insulin secretion.
    Sjöholm A
    Anticancer Res; 1993; 13(5A):1283-5. PubMed ID: 8239498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity.
    Sjöholm A; Arkhammar P; Welsh N; Bokvist K; Rorsman P; Hallberg A; Nilsson T; Welsh M; Berggren PO
    J Clin Invest; 1993 Oct; 92(4):1910-7. PubMed ID: 8408643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased glucose oxidation and contents of insulin and ATP in polyamine-depleted rat insulinoma cells (RINm5F).
    Sjöholm A; Welsh N; Hoftiezer V; Bankston PW; Hellerström C
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):533-40. PubMed ID: 1859381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium butyrate inhibits rat insulinoma cell proliferation without affecting the cellular insulin content or insulin release.
    Sjöholm A
    Anticancer Drugs; 1993 Apr; 4(2):259-63. PubMed ID: 8490204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines inhibit proliferation and insulin secretion by clonal rat insulinoma cells (RINm5F) non-synergistically and in a pertussis toxin-insensitive manner.
    Sjöholm A
    Immunol Lett; 1991 Sep; 30(1):81-6. PubMed ID: 1959944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of insulinoma cell proliferation and insulin accumulation by peptides and second messengers.
    Sjöholm A
    Ups J Med Sci; 1995; 100(3):201-16. PubMed ID: 8808183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour formation and insulin secretion by clonal RINm5F cells following repeated subcutaneous transplantation in NEDH rats.
    Flatt PR; DeSilva MG; Swanston-Flatt SK; Powell CJ; Marks V
    J Endocrinol; 1988 Sep; 118(3):429-37. PubMed ID: 2846737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion in vivo and in vitro from transplantable NEDH rat insulinoma and derived clonal RINm5F cell line.
    Flatt PR; DeSilva M; Swanston-Flatt SK; Marks V
    Diabetes Res; 1987 Oct; 6(2):85-90. PubMed ID: 2827934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of somatostatin action in RINm5F cells in culture: preliminary evidence for possible altered G protein function.
    McLeod MK; Kothary P; Warnock M; Fukuuchi A; Tutera AM
    J Surg Res; 1992 Nov; 53(5):439-44. PubMed ID: 1359194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamines regulate serine/threonine protein phosphatases in insulin-secreting cells.
    Sjöholm A; Honkanen RE
    Pancreas; 2000 Jan; 20(1):32-7. PubMed ID: 10630381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of polyamines in mitogenic and secretory responses of pancreatic beta-cells to growth factors.
    Sjöholm A; Welsh N; Sandler S; Hellerström C
    Am J Physiol; 1990 Nov; 259(5 Pt 1):C828-33. PubMed ID: 2240196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A stimulation of glucose-induced insulin secretion in MIN6 cells.
    Ebihara K; Fukunaga K; Matsumoto K; Shichiri M; Miyamoto E
    Endocrinology; 1996 Dec; 137(12):5255-63. PubMed ID: 8940343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells.
    Sjöholm A
    Am J Physiol; 1993 Mar; 264(3 Pt 1):C501-18. PubMed ID: 8460662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of altered Ca2+ and Mg2+ concentrations on proliferation and functional differentiation of the clonal insulin-producing cells RINm5F.
    Hoftiezer V; Berggren PO; Hellman B
    Cancer Lett; 1985 May; 27(1):7-14. PubMed ID: 2988757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible morphological and functional abnormalities of RINm5F cells cultured on polystyrene sulfonate beads.
    Aubert N; Reach G; Serne H; Jozefowicz M
    J Biomed Mater Res; 1987 May; 21(5):585-601. PubMed ID: 3034913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytotoxic drugs and inhibitors of insulin secretion on a serially transplantable rat insulinoma and cultured rat insulinoma cells.
    Flatt PR; Swanston-Flatt SK; Tan KS; Marks V
    Gen Pharmacol; 1987; 18(3):293-7. PubMed ID: 3032737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological differences in a rat insulinoma cell line obtained from different laboratories do not affect binding of human anti-islet immunoglobulins.
    McEvoy RC; Franklin BH; Ginsberg-Fellner F
    Diabetes Res; 1986 Sep; 3(7):339-44. PubMed ID: 3022981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
    Jehle PM; Jehle D; Fussgänger RD; Adler G
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cells.
    Flatt PR; Shiber O; Hampton SM; Marks V
    Diabetes Res; 1990 Feb; 13(2):55-9. PubMed ID: 1965428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.